Key facts
- Notable investors include Kairous Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Mglobal
- ·The full record, as it builds
Funding rounds
No funding rounds for Mglobal are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mglobal
Manufacturer of medical devices designed to improve global healthcare accessibility. The company operates in the medical device and healthcare industry, focusing on in vitro diagnostics (IVD), hemodialysis, and a diversified portfolio covering ophthalmology, otolaryngology (ENT), trauma management, and pain and vertigo management. Its value proposition centers on producing consumables across high, medium, and low value categories, leveraging ASEAN market opportunities, and serving as a benchmark bridge connecting China with global medical resources.
- Sector
- Healthcare
- HQ
- Hong Kong
- Founded
- 2025
- Ownership
- Privately Held (backing)
Mglobal doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mglobal shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mglobal in its N-PORT filings yet. We sweep new filings monthly.